Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
RTX-001 by Resolution Therapeutics for Decompensated Cirrhosis: Likelihood of Approval
RTX-001 is under clinical development by Resolution Therapeutics and currently in Phase II for Decompensated Cirrhosis. According to GlobalData, Phase...